Article
Cancer stem cells and HER2 positive breast cancer: The story so far
21 Feb 2016
Abstract excerpt
Human Epidermal Growth Factor Receptor type 2 (HER2) gene amplification and/or protein overexpression is observed in patients suffering from HER2+ breast cancer. This subtype of breast cancer has improved prognosis due to availability of anti-HER2 therapy. However, drug resistance and tumor recurrence still remains a major concern. Cancer Stem Cells (CSCs) are believed to constitute the subset of cell population...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
